Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
In laboratory studies, synthetic BPC-157 is reported to: Support the healing of wounds, and certain injuries Promote recovery after tissue traumas Limit the impact of systemic insults including hyperkalemia and hypermagnesia Promisingly, few studies are reporting any adverse reactions to the administration of BPC 157
These treatments are not FDA-approved and are not intended to diagnose, treat, cure, or prevent any medical condition
Unlike many peptide-based compounds that require specialized delivery systems (such as injectable carriers) or are rapidly broken down by digestive enzymes, BPC-157's inherent resistance to hydrolysis and enzymatic digestion allows for its potential oral administration
Cet actif a dmontr une efficacit remarquable dans des tudes comparatives
It's one of the most frequently submitted drug codes alongside 96372, and it's also one of the most frequently denied under Medicare when the diagnosis doesn't meet LCD criteria
